{'fraction_non_alphanumeric': 0.027166882276843468, 'fraction_numerical': 0.00517464424320828, 'mean_word_length': 5.2926829268292686, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Intractable diarrhoea with a lung neuroendocrine tumour

© Author(s) (or their employer(s)) 2021. No commercial reuse. See rights and permissions. Published by BMJ. ABSTRACT Patients with neuroendocrine tumours are at risk of developing Carcinoid Syndrome. This may result in symptoms such as diarrhoea and flushing. We present a case of a lady with known Crohn’s disease and an atypical lung neuroendocrine tumour, who developed intractable diarrhoea. Multiple specific and nonspecific pharmacological approaches failed to control her diarrhoea. Upon cessation of such treatments, her symptoms did not worsen. The case highlights the need for further research into the management of diarrhoea in this context, and the need to review and deprescribe ineffective treatments.